Nous contacter

Tel. +33(0)2 53 00 91 22

Mob. +33(0)6 83 82 26 78

Mail: contact@labcom-risca.com

  • LinkedIn Social Icône
  • Facebook
  • Twitter
  • YouTube

Qui sommes-nous ?

Le laboratoire SPHERE (methodS for Patients-centered outcomes and HEalth REsearch, INSERM UMR 1246, Université de NantesUniversité de Tours) et la société IDBC (groupe A2com) ont décidé de créer ensemble le Laboratoire Commun RISCA (Research in Informatics and Statistics for Cohort-based Analyses)

 

s'INSCRIRE à NOTRE NEWSLETTER?

The EVALADD cohort

Studied population

The patients treated in the Nantes University Hospital (department of addictive disorders). Patients with high-level disorders or difficulties in reading or writing the French language, as well as patients under guardianship, are not included in the study.

Objectives

The principal is to determine the determinants of the addictions and consequently to improve the therapies and preventive strategies. More precisely, the investigators aim to:
  • Define the different patients' trajectories by considering the baseline characteristics, the treatments, and the outcomes.
  • To propose an adaptation of the therapies according to these profiles and to avoid discontinuity in the care.

Collected data

A multi-axial clinical systematic evaluation was standardized and performed at the begining of the care, at 6-month, at 1-year, and every year afterwards. The evaluation was composed by a questionnaire which was the basis for a semi-structured interview and an auto-questionnaire.

Team

Marie Grall-Bronnec
Professor in Addictology

marie.bronnec@chu-nantes.fr

Tél : +33 (0) 2 40 84 76 20

In charge of the clinical investigation unit in Addictology - Institut Fédératif des Addictions Comportementales (IFAC) du CHU de Nantes

 

UMR 1246 SPHERE « MethodS for Patients-centered outcomes and HEalth REsearch».

Coordinator of clinical studies – Institut Fédératif des Addictions Comportementales (IFAC) du CHU de Nantes

 

UMR 1246 SPHERE « MethodS for Patients-centered outcomes and HEalth REsearch».

Gaelle Challet, PhD

gaelle.bouju@chu-nantes.fr

Tél: +33 (0) 2 40 84 76 20

Home > Presentation > Evaladd cohort